Skin Excision Evaluation Program
The Skin Excision Evaluation Program enables general practitioners, who refer skin histology specimens to Australian Clinical Labs, to submit provisional diagnoses for cases where histological evaluation is needed. Participants enrolled in this valuable CPD program can submit both biopsy and excision specimens with a provisional diagnosis, confirming their dermatological diagnostic proficiency.
A CPD program that benefits your patients
Our Skin Excision Evaluation Program provides a beneficial education opportunity for general practitioners. The program aids skin cancer management for patients by improving the identification of high-risk lesions so they can be treated at an early stage.
Through consistent feedback from our unique reporting portal, you will see an increase in the accuracy of your diagnoses, an improvement in your clinical skills, and an increase in your confidence with patients. Monitoring adequate margin control and appropriate removal of pathological lesions can reduce patient risk of subsequent invasive procedures and risk of cancer recurrence, scarring, and infection.
Compare your performance with your peers
As you progress through the program, your results are then made available to you via a monthly Skin Excision Evaluation Report, which highlights your performance against that of your peers and national benchmarks, while maintaining the confidentiality of all clinicians.
Access to your personal clinical audit statistics is available through the doctor's portal. This simple online platform will help you review monthly Audit reports and compare your provisional diagnostic and margin control skills beside your state and national fellow participants.
Australian Clinical Labs is a RACGP approved activity provider and has two Education Activity Representatives (EARs). Therefore, your participation in our exclusive Skin Excision Evaluation Program makes you eligible for Continuing Professional Development (CPD) points.